Skip Nav Destination
Issues
Featured Articles
Clinical Trials
Targeting Vascular Endothelial Growth Factor for Relapsed and Refractory Adult Acute Myelogenous Leukemias: Therapy with Sequential 1-β-d-Arabinofuranosylcytosine, Mitoxantrone, and Bevacizumab
Judith E. Karp; Ivana Gojo; Roberto Pili; Christopher D. Gocke; Jacqueline Greer; Chuanfa Guo; David Qian; Lawrence Morris; Michael Tidwell; Helen Chen; James Zwiebel
Successful Engraftment After Reduced-Intensity Umbilical Cord Blood Transplantation for Adult Patients with Advanced Hematological Diseases
Shigesaburo Miyakoshi; Koichiro Yuji; Masahiro Kami; Eiji Kusumi; Yukiko Kishi; Kazuhiko Kobayashi; Naoko Murashige; Tamae Hamaki; Sung-Won Kim; Jun-ichi Ueyama; Shin-ichiro Mori; Shin-ichi Morinaga; Yoshitomo Muto; Shigeru Masuo; Mineo Kanemaru; Tatsuyuki Hayashi; Yoichi Takaue; Shuichi Taniguchi
Molecular Oncology, Markers, Clinical Correlates
Gene-Expression Profile Changes Correlated with Tumor Progression and Lymph Node Metastasis in Esophageal Cancer
Eiji Tamoto; Mitsuhiro Tada; Katsuhiko Murakawa; Minoru Takada; Gaku Shindo; Ken-ichi Teramoto; Akihiro Matsunaga; Kazuteru Komuro; Motoshi Kanai; Akiko Kawakami; Yoshie Fujiwara; Nozomi Kobayashi; Katsutoshi Shirata; Norihiro Nishimura; Shun-ichi Okushiba; Satoshi Kondo; Jun-ichi Hamada; Takashi Yoshiki; Tetsuya Moriuchi; Hiroyuki Katoh
Mitogen-Activated Protein Kinase Phosphatase-1 Is Overexpressed in Non-Small Cell Lung Cancer and Is an Independent Predictor of Outcome in Patients
Silvestre Vicent; Mercedes Garayoa; José M. López-Picazo; María D. Lozano; Gemma Toledo; Frederik B. J. M. Thunnissen; Ramón G. Manzano; Luis M. Montuenga
Magnetic Resonance Imaging Measurements of the Response of Murine and Human Tumors to the Vascular-Targeting Agent ZD6126
Jeffrey L. Evelhoch; Patricia M. LoRusso; Zhanquan He; Zachary DelProposto; Lisa Polin; Thomas H. Corbett; Peter Langmuir; Catherine Wheeler; Andrew Stone; Joanna Leadbetter; Anderson J. Ryan; David C. Blakey; John C. Waterton
Experimental Therapeutics, Preclinical Pharmacology
Changes in Gene Expression Induced by Phosphorothioate Oligodeoxynucleotides (Including G3139) in PC3 Prostate Carcinoma Cells Are Recapitulated at Least in Part by Treatment with Interferon-β and -γ
Luba Benimetskaya; Timo Wittenberger; C. A. Stein; Hans-Peter Hofmann; Claudia Weller; Johnathan C. Lai; Paul Miller; Volker Gekeler
Regular Articles
Clinical Trials
Research Articles
Molecular Oncology, Markers, Clinical Correlates
High Expression Levels of X-Linked Inhibitor of Apoptosis Protein and Survivin Correlate with Poor Overall Survival in Childhood de Novo Acute Myeloid Leukemia
Ingo Tamm; Stephan Richter; Doreen Oltersdorf; Ursula Creutzig; Jochen Harbott; Frank Scholz; Leonid Karawajew; Wolf-Dieter Ludwig; Christian Wuchter
Molecular Marker Profiles Predict Locoregional Control of Head and Neck Squamous Cell Carcinoma in a Randomized Trial of Continuous Hyperfractionated Accelerated Radiotherapy
Francesca M. Buffa; Søren M. Bentzen; Frances M. Daley; Stanley Dische; Michele I. Saunders; Paul I. Richman; George D. Wilson
Biologically Different Subgroups of Invasive Ductal Carcinoma of the Pancreas: Dpc4 Status According to the Ratio of Intraductal Carcinoma Components
Hidenori Takahashi; Tatsuya Oda; Takahiro Hasebe; Yasuyuki Aoyagi; Taira Kinoshita; Masaru Konishi; Toshio Nakagohri; Kazuto Inoue; Shinichiro Takahashi; Hiroshi Kawahira; Morito Monden; Atsushi Ochiai
High Specificity of Quantitative Excision Repair Cross-Complementing 1 Messenger RNA Expression for Prediction of Minor Histopathological Response to Neoadjuvant Radiochemotherapy in Esophageal Cancer
Ute Warnecke-Eberz; Ralf Metzger; Futoshi Miyazono; Stephan E. Baldus; Susanne Neiss; Jan Brabender; Hartmut Schaefer; Walter Doerfler; Elfriede Bollschweiler; Hans P. Dienes; Rolf P. Mueller; Peter V. Danenberg; Arnulf H. Hoelscher; Paul M. Schneider
Carcinoembryonic Antigen Messenger RNA Expression Using Nested Reverse Transcription-PCR in the Peripheral Blood During Follow-up Period of Patients Who Underwent Curative Surgery for Biliary-Pancreatic Cancer: Longitudinal Analyses
Yuko Mataki; Sonshin Takao; Kousei Maemura; Shinichiro Mori; Hiroyuki Shinchi; Shoji Natsugoe; Takashi Aikou
High-Level Expression of the Coxsackievirus and Adenovirus Receptor Messenger RNA in Osteosarcoma, Ewing’s Sarcoma, and Benign Neurogenic Tumors among Musculoskeletal Tumors
Wenguang Gu; Akira Ogose; Hiroyuki Kawashima; Masayuki Ito; Tomoyuki Ito; Atsushi Matsuba; Hiroshi Kitahara; Tetsuo Hotta; Kunihiko Tokunaga; Hiroshi Hatano; Tetsuro Morita; Sayuri Urakawa; Tatsuya Yoshizawa; Hiroyuki Kawashima; Ryozo Kuwano; Naoto Endo
Experimental Therapeutics, Preclinical Pharmacology
Special Section
Biomarkers, Surrogate End Points, and the Acceleration of Drug Development for Cancer Prevention and Treatment: An Update Prologue
Gary J. Kelloff; Robert C. Bast, Jr.; Donald S. Coffey; Anthony V. D’Amico; Robert S. Kerbel; John W. Park; Raymond W. Ruddon; Gordon J. S. Rustin; Richard L. Schilsky; Caroline C. Sigman; George F. Vande Woude
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds